Skip to main content

Table 1 Characteristics of NSCLC patients

From: Katanin P60: a potential biomarker for lymph node metastasis and prognosis for non-small cell lung cancer

Items

NSCLC patients (N = 265)

Age (years)

 Mean ± SD

62.0 ± 10.6

 Median (IQR)

62.0 (55.0–68.0)

Sex, No. (%)

 Male

205 (77.4)

 Female

60 (22.6)

History of smoke, No. (%)

150 (56.6)

History of drink, No. (%)

103 (38.9)

Hypertension, No. (%)

95 (35.8)

Hyperlipidemia, No. (%)

87 (32.8)

Diabetes, No. (%)

44 (16.6)

Pathological grade, No. (%)

 G1

44 (16.6)

 G2

160 (60.4)

 G3

61 (23.0)

Tumor size (cm)

 Mean ± SD

5.3 ± 2.1

 Median (IQR)

5.0 (4.0–7.0)

LYN metastasis, No. (%)

93 (35.1)

TNM stage, No. (%)

 I

86 (32.5)

 II

90 (34.0)

 III

89 (33.5)

CEA (ng/mL)

 Mean ± SD

47.7 ± 172.8

 Median (IQR)

6.2 (2.9–27.6)

  1. NSCLC non-small cell lung carcinoma, SD standard deviation, LYN lymph node, CEA carcinoembryonic antigen, IQR interquartile range